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Background: Cancer-associated stromal cells interact with carci-
noma cells and thus participate in tumor growth. Our aim was to 
characterize the ultrastructure and contractile properties of stromal 
cells in collagen gel cultured from lung cancer of various histological 
types and from tumor-free lung.
Methods: Cells cultured from lung cancer (13 adenocarcinomas, 
six squamous cell carcinomas, one adenosquamous carcinoma, and 
one pleomorphic carcinoma) and tumor-free lung were analyzed by 
transmission electron microscopy and three-dimensional collagen 
gel contraction assays. The expression of α-smooth muscle actin 
 (α-SMA), a recognized myofibroblast marker, was examined by 
immunoelectron microscopy from individual cells and by Western 
blotting from the whole cultured cell population.
Results: According to their ultrastructure, the cell lines were com-
posed of fibroblastic and myofibroblastic cells. In electron micros-
copy, cells of lung cancer exhibited more myofibroblastic features 
displaying higher amounts of actin belts (p = 0.057) and α-SMA 
labeling (p = 0.010) than cells from tumor-free lung. Myofibroblasts 
cultured from lung cancer of smokers expressed less α-SMA labeling 
(p = 0.013) than counterparts from nonsmokers. Western blotting 
revealed that cancer-associated fibroblasts expressed more α-SMA 
(p = 0.006) than cells from tumor-free lung, whereas cells from 
tumor-free central lung of smokers showed less α-SMA (p = 0.039) 
than counterparts from nonsmokers. Cells cultured from cancer con-
tracted more in collagen gel than those from tumor-free lung. The 
contractile capacity in collagen gel correlated with the frequency 
of extracellular component of fibronexus by transmission electron 
microscopy.
Conclusions: Lung cancer–associated myofibroblasts are different 
both ultrastructurally and functionally when compared with cells cul-
tured from tumor-free lung. Smoking altered myofibroblastic pheno-
type, regardless of their origin.
Key Words: Cancer-associated fibroblast, Electron microscopy, 
Tumor stroma, Smoking.
(J Thorac Oncol. 2014;9: 664–674)
Interactions between carcinoma and stromal cells are medi-ated by cytokines, such as transforming growth factor-β1 
(TGF-β1), which activate the extracellular matrix (ECM) and 
stromal cells.1 Similar to some fibrotic lung reactions, neo-
plasms are also characterized by the appearance of myofibro-
blasts that are fibroblastic stromal cells expressing α-smooth 
muscle actin (α-SMA) and displaying a distinctive ultrastruc-
ture.2 These cells have an increased contractile capacity, and 
they participate in ECM remodeling.3 The stromal cells of 
tumors are a heterogeneous group of cells, including fibro-
blasts, myofibroblasts, inflammatory, and endothelial cells. In 
cell culture conditions, fibroblasts and myofibroblasts, often 
called cancer-associated fibroblasts (CAF), grow on the cul-
ture plate while other cell types fail to thrive. Thus, if one 
uses α-SMA or vimentin as markers, these will not recognize 
all types of CAF.4,5 Our recent study indicated that cells cul-
tured from bronchoalveolar lavage (BAL) fluid samples of 
the patients with fibrotic and interstitial lung diseases were 
composed of fibroblasts and myofibroblasts but shared also 
similarities with progenitor-type cells.6,7 There are rather few 
studies in which electron microscopy has been used to exam-
ine stromal cells in lung tumors.8,9
The ultrastructure of stromal myofibroblasts in tumors 
has been investigated in different organs, but they have never 
been compared in a systematic manner in lung cancer speci-
mens.10 At present, there is no specific marker for a myofi-
broblast, and thus, an electron microscopic characterization 
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is needed for the ultimate recognition.10 The ultrastructure of 
myofibroblasts is identified by the dilated rough endoplasmic 
reticulum (rER), adherens-type junctions, and most notably, 
a fibronexus (FNX) structure that is composed of prominent 
bundles of intracellular α-SMA and extracellular bundles of 
fibronectin (Fn), as described previously.6,11–15
We aimed to characterize stromal cells cultured from 
different histological types of lung cancers and tumor-free 
peripheral and central lung tissue from nonsmokers and smok-
ers. Cultured cells were analyzed by Western blotting and 
three-dimensional collagen gel contraction assays. Cultured 
myofibroblasts were investigated individually to elucidate 
ultrastructure and ultrastructural localization of α-SMA 
examination in the transmission electron microscope (TEM) 
and the immunoelectron microscope (IEM). The results were 
concurrently evaluated, taking into consideration the histolog-
ical type of the carcinoma and smoking habits.
PATIENTS AND METHODS
More information about Methods is available in the 
Supplementary Data (Supplemental Digital Content 1, 
http://links.lww.com/JTO/A551), Supplementary Table 1 
(Supplemental Digital Content 2, http://links.lww.com/JTO/
A552), and Supplementary Figure 1 (Supplemental Digital 
Content 3, http://links.lww.com/JTO/A553).
Ethical Considerations
The study received approval from the Ethical Committee 
of Northern Ostrobothnia Hospital District in Oulu (February 
2008). The patients were interviewed before surgery, and all 
subjects gave their written informed consent.
Study Subjects
The patients underwent surgery for lung cancer during 
2008 to 2012 in Oulu University Hospital. Patients (n = 23) 
were divided into lifelong nonsmokers (n = 5) and smokers 
(n = 18). The demographic data are described in Table 1.
Cell Culture
Tissue samples from cancer (n = 21, six squamous cell 
carcinomas, 13 adenocarcinomas, one adenosquamous carci-
noma, and one pleomorphic carcinoma), tumor-free central 
airways (n = 14), and tumor-free peripheral lung (n = 22) from 
a total of 23 patients (six women and 17 men) were collected 
for the culture of fibroblastic cells. The study material con-
sisted of 20 patients, in which both cancer and corresponding 
tumor-free peripheral lung samples were obtained. In addition, 
two female patients provided tumor-free peripheral and central 
lung, but not cancer samples, and one male patient for which 
there was a cancer sample, but no peripheral or central lung 
specimens were available for research. An experienced pulmo-
nary pathologist (E.L.-B.) collected lung tissue specimens for 
cell culture during the diagnostic sample preparation. Samples 
were taken only if this did not disturb the routine diagnostics, 
and thus, the samples from tumor-free central lung or cancer 
were not available from all patients. Samples were processed 
and cells were cultured, as described previously.6 The cells were 
examined in passages 2, 3, or 4. The flow chart of the methods 
is illustrated in the Supplementary Figure 1 (Supplemental 
Digital Content 3, http://links.lww.com/JTO/A553).
All cultured cells were positive for vimentin and extra 
type III domain A-fibronectin, whereas staining for E-cadherin 
was negative. Variable numbers of spindle-shaped cells posi-
tive for α-SMA, clearly myofibroblasts, were observed in all 
samples. Some scattered cells were positive for desmin (Fig. 1). 
Immunocytochemical results supported electron microscopic 
findings that the cell lines were composed of mesenchymal cells, 
that is, fibroblasts and myofibroblasts, but not epithelial cells.
Transmission Electron Microscopy
The cells with typical ultrastructural features of myo-
fibroblasts were called lung cancer–associated myofibro-
blasts (CAM) when examined in the electron microscope. A 
comparison of myofibroblastic ultrastructural features was 
performed between CAM and myofibroblasts of tumor-free 
peripheral and central lung compartments. Although cultured 
cell populations were composed of fibroblasts and myofibro-
blasts, TEM analyses focused on myofibroblasts, a subgroup 
of CAF. The whole heterogeneous stromal cell population 
was designated as CAF when they were analyzed by the gel 
contraction assay and Western blotting. A total of 57 patient 
samples were analyzed by TEM. The cells were cultured and 
the samples were prepared, as described earlier.6
Quantification of TEM
The quantification of TEM features was done, as previ-
ously described.6 In brief, myofibroblastic ultrastructural fea-
tures were evaluated as follows: peripheral actin filaments with 
focal densities, the frequency of extracellular component of 
FNX, type and orientation of FNX, pericellular ECM, dilated 
rER, and occurrence of adherens-type junctions. The pattern 
of track-like FNX was divided into three subtypes based on 
the localization and pattern of extracellular component of FNX 
(Fig. 2). Two authors (H.M.K. and R.T.S.) separately evaluated 
TABLE 1.  Clinical Characteristics of the Patients with Lung Cancer
Adenocarcinoma (n = 13) Squamous Cell Carcinoma (n = 6) Other (n = 2) p Value
Age (yr) 67 (7) 68 (7) 74 (7) NS
Sex M:F 10:3 5:1 2:0 NS
Nsm:smoker 2:11 1:5 1:1 NS
Pack-years 41 (21) 35 (29) 35 (50) NS
Values are expressed as mean (SD). Smoking represents the number of patients (%).
Nsm, nonsmoker; NS, not significant; other, adenosquamous carcinoma (n = 1) and pleomorphic carcinoma (n = 1).
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the semiquantitative TEM findings, and there was almost per-
fect agreement (p < 0.001, Fisher; κ coefficient = 0.856).16
IEM and Western Blotting
All cell lines (n = 57) cultured from different lung com-
partments were analyzed by IEM for α-SMA labeling and by 
Western blotting for α-SMA quantification. The cells were cul-
tured, the samples were prepared, and α-SMA was quantified, as 
described earlier.6 Western blotting of cells cultured from periph-
eral lung has been published previously.17 Details of the antibod-
ies used in IEM, Western blotting, and immunocytochemistry 
are shown in the Supplementary Table 1 (Supplemental Digital 
Content 2, http://links.lww.com/JTO/A552).
Collagen Gel Contraction Assay
To study the functional properties, CAF (six adenocar-
cinomas and four squamous cell carcinomas) and cells from 
tumor-free peripheral lung of 10 patients including two women 
and eight men (two lifelong nonsmokers and eight smokers) 
were evaluated in the gel contraction assay. Contraction assays 
were conducted as four replicates, as previously described.18
Statistical Analyses
Statistical analyses were performed by Statistical 
Package for the Social Sciences (version 20.0.0; IBM SPSS 
Inc., Chicago, IL) using χ2 test or Fisher’s exact test for cat-
egorized data and Mann-Whitney U test, independent samples 
t test, paired samples t test, Kruskal-Wallis test, or analysis of 
variance for continuous data. Values of p less than 0.050 were 
considered as significant and indicated as * less than 0.050, 
** less than 0.010, and *** less than 0.001.
RESULTS
Ultrastructural Analyses of Cultured Cells from  
Cancerous and  Tumor-Free Lung by  
Electron Microscopy
CAM and myofibroblasts from tumor-free  
peripheral and central lung
In vitro cultured cells from lung cancer, tumor-free 
peripheral, and central lung samples were mixtures of fibro-
blasts and myofibroblasts that were recognized by the ultra-
structural features, such as the presence of prominent actin 
FIGURE 1.  Immunocytochemical characterization 
of cells cultured from lung cancer and tumor-free 
lung. A, cancer-associated fibroblasts in which  
some cells were positive for α-smooth muscle  
actin  (α-SMA) (arrows) indicative of the typical  
phenotype of a myofibroblast. All cells were positive 
for extra type III domain A-fibronectin (EDA-Fn)  
(B, arrows) and vimentin (C, arrows). Positive cells 
for desmin (D, arrows) were occasionally observed. 
Immunocytochemical staining for E-cadherin 
(E, arrows) was negative, showing that the cell lines 
did not include epithelial cells. F, Negative control. 
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filaments with focal densities, extracellular filamentous com-
ponent of FNX, adherens-type junctions, dilated rER, the 
deposition of ECM, and the type of FNX as described pre-
viously6,11–14 and presented in the Table 2. The results of the 
semiquantitative TEM analyses of myofibroblasts derived 
from different pulmonary regions are shown in Table 2 and 
a summary of the main ultrastructural results in Table 3. 
CAM had a tendency to exhibit more prominent intracel-
lular actin belts than peripheral and central myofibroblasts 
as a group (p = 0.057, χ2, Fig. 3A, B). CAM and particu-
larly  adenocarcinoma-derived CAM displayed a tendency 
to express more frequently track-like FNX curved subtypes 
(p = 0.055 and p = 0.057, χ2, respectively) when compared 
with peripheral myofibroblasts. CAM derived from squamous 
cell carcinoma displayed more prominent deposition of ECM 
than those counterparts from adenocarcinoma, but this dif-
ference was not statistically significant (p = 0.062, Fisher, 
Fig. 3C, Table 3).
CAM and myofibroblasts from nonsmokers and smokers.
CAM from smokers expressed fewer tandem-like FNXs 
than those counterparts of nonsmokers (p = 0.042, Fisher). 
Myofibroblasts from tumor-free peripheral lung of smokers 
had a tendency to accumulate less ECM than their counterparts 
from nonsmokers (p = 0.095, Fisher). Myofibroblasts from 
tumor-free central lung of smokers exhibited  adherens-type 
FIGURE 2.  Electron micrographs and simpli-
fied drawings (not in scale) of the classification of 
 track-like fibronexus (FNX) subtypes found to associ-
ate with myofibroblasts cultured from lung cancer 
and tumor-free lung. A, C, and E, Ultrastructures of 
the cell surface track-like FNXs, which are orientated 
as straight and rigid (A), curved (C), and fragmen-
tary and scanty (E). The myofibroblast phenotype 
is recognized by the ultrastructural features such 
as the presence of dense actin belt (arrowhead), 
dilated rough endoplasmic reticulum (arrow), and 
cell surface fibronectin bundle (asterisk). A scale bar is 
shown. B, D, and F, Schematic drawings of myofi-
broblasts with typical ultrastructural features. The cell 
surface track-like FNXs can be found in different pat-
terns (red line): straight and rigid (B), curved (D), and 
fragmentary, which is closely associated to the cell 
membrane (F). Descriptions of drawings are shown.
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TABLE 2.  Semiquantitative TEM Analyses of the Ultrastructural Features of Myofibroblasts Cultured from Lung Cancer and 
Tumor-Free Peripheral and Central Lung
CAM (n = 21) Peripheral Myofibroblasts (n = 22) Central Myofibroblasts (n = 14)
Actin filamentsa + 9 (43) 15 (68) 10 (71)
++ 10 (48) 6 (27) 4 (29)
+++ 2 (9) 1 (5) 0 (0)
Extracellular component of 
fibronexusa–c
− 0 (0) 2 (9) 1 (7)
+ 7 (33) 7 (32) 3 (21)
++ 11 (52) 12 (55) 10 (71)
+++ 3 (14) 1 (5) 0 (0)
ECMa,b − 11 (52) 14 (64) 11 (79)
+ 7 (33) 5 (23) 2 (14)
++ 3 (14) 3 (14) 1 (7)
+++ 0 (0) 0 (0) 0 (0)
Focal densitiesc 18 (85) 15 (68) 9 (64)
Dilated rERa,c 19 (90) 18 (82) 10 (71)
Adherens-type junction 17 (81) 20 (91) 11 (79)
Track-like 19 (90) 20 (91) 13 (93)
Straight, rigid 17 (81) 13 (59) 11 (77)
Curveda 10 (48) 4 (18) 4 (29)
Fragmentary, scanty 15 (71) 13 (59) 10 (71)
Tandem-like 10 (48) 8 (36) 4 (29)
Plaque-likea 2 (9.5) 2 (9) 0 (0)
Classification: −, not found; +, low; ++, moderate; +++, strong expression (see criteria for grading of expressions in Supplementary Data 1; Supplemental Digital Content 1, 
http://links.lww.com/JTO/A551, and our previous study).6
Numbers indicate the patient samples that express certain features (percentage in parenthesis).
aThe expression of actin filaments correlated with the frequency of extracellular component of FNX (p = 0.005, Fisher), the plaque type of FNX (p = 0.017, Fisher), the curved 
subtype of track-like FNX (p < 0.001, Fisher), amount of ECM filaments (p = 0.005, Fisher), and the expression of dilated rER (p = 0.038, χ2).
bThe frequency of extracellular component of FNX correlated with the amount of ECM (p = 0.026, Fisher).
cThe presence of dilated rER correlated with the frequency of extracellular component of FNX (p = 0.026, Fisher) and the occurrence of focal densities within actin belts 
(p = 0.047, Fisher).
CAM, cancer-associated myofibroblasts; ECM, the deposition of extracellular matrix nearby the cells; FNX, fibronexus;rER, rough endoplasmic reticulum.
TABLE 3.  The Main TEM and IEM Findings of Myofibroblasts Cultured from Different Lung Compartments
Characteristics (Method) Source of Myofibroblasts p Value
Increased (↑) or 
Decreased (↓) in
Ultrastructure (TEM)
  Intracellular actin belts CAM Peripheral and central myofibroblasts as a group 0.057 ↑ CAM
  Track-like FNX curved subtype CAM Peripheral myofibroblasts 0.055 ↑ CAM
  Deposition of ECM CAM (SCC) CAM (AC) 0.062 ↑ SCC
Peripheral myofibroblasts (sm) Peripheral myofibroblasts (nsm) 0.095 ↓ Smoker
  Tandem-like FNX CAM (sm) CAM (nsm) 0.042a ↓ Smoker
  Adherens-type junction Central myofibroblasts (sm) Central myofibroblasts (nsm) 0.066 ↑ Smoker
Expression of α-SMA (IEM)
CAM Peripheral myofibroblasts 0.010a ↑ CAM
CAM Peripheral myofibroblasts (nsm) 0.035a ↑ CAM
CAM Central myofibroblasts 0.083 ↑ CAM
CAM (sm) CAM (nsm) 0.012a ↓ Smoker
Smoking habit of the patients was taken into consideration.
ap < 0.05.
↑, increased; ↓, decreased; α-SMA, α-smooth muscle actin; AC, adenocarcinoma; CAM, cancer-associated myofibroblasts; ECM, extracellular matrix; FNX, fibronexus; 
IEM, immunoelectron microscopy; nsm, nonsmoker; SCC, squamous cell carcinoma; sm, smoker; TEM, transmission electron microscopy.
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cell-cell junctions in every sample, whereas only 40% of myo-
fibroblasts from nonsmokers expressed adherens junctions 
(p = 0.066, Fisher; Fig. 3E, Table 3).
Correlation of myofibroblastic features.
When studied all cell samples as a group, myofibro-
blasts with moderate or strong expression of peripheral actin 
belts possessed more often dilated rER (p = 0.038). The quan-
tity of intracellular actin filaments correlated with the amount 
of ECM (p = 0.005), the frequency of extracellular component 
of FNX (p = 0.005), and more specifically, the occurrence of 
plaque-like FNX (p = 0.017, Fig. 3F) and the track-like FNX 
curved subtype (p < 0.001, Table 2).
All three types of FNXs were observed, that is, (1) long 
and well-defined track-like; (2) dense, cloud-like plaque-like; 
and (3) tandem-like located at the end of cell extensions. We 
observed that track-like FNX could be exhibited in several 
patterns, and thus, it was further divided into three subtypes: 
(1) straight and rigid, (2) curved, and (3) fragmentary and 
scanty with a tight association to the cell membrane. Examples 
of ultrastructural track-like FNX subtypes are shown in 
Figure 2. Almost all, 51 (90 %) of 57 samples, expressed 
track-like FNXs with straight and rigid subtype being the 
form most often observed (Fig. 3A). The frequency of extra-
cellular component of FNX correlated with the amount of 
ECM (p = 0.026, Table 2). The vast majority, 84.7%, of sam-
ples included myofibroblasts with adherens-type junctions, 
with most being detected in myofibroblasts from tumor-free 
peripheral lung. In general, the expression of ECM around 
the myofibroblasts was scanty. Many (88.1%) myofibroblasts 
exhibited little or no ECM. Plaque-like FNXs were observed 
in 8.5% of samples, of which the majority (60%) was located 
in CAM. Only 40.7% of the samples, especially CAM and 
myofibroblasts from tumor-free peripheral lung, exhibited 
tandem-like FNXs (Fig. 3D).
Immunoelectron Microscopic Findings
CAM and myofibroblasts from tumor-free  
peripheral and central lung.
Peripheral actin filaments in CAM, peripheral, and central 
myofibroblasts showed positive labeling for α-SMA (Fig. 4). 
FIGURE 3.  Electron micrographs display the typical 
ultrastructure of lung cancer-associated myofibro-
blasts (CAM) and myofibroblasts from tumor-free 
lung. A, The typical ultrastructure of CAM with a 
dense actin belt (arrowhead), dilated rER (arrow), 
and cell surface Fn organized as straight and rigid 
subtype of track-like FNX (asterisk) that longitu-
dinally is orientated with the cell membrane. B, 
A fibroblast with loose peripheral actin filaments 
(arrowhead), thin rER (arrow), and a lack of extracel-
lular Fn bundle. C, CAM from squamous cell carci-
noma expressing a relative amount of pericellular 
matrix (white asterisk). The extracellular component 
of FNX (black asterisk) is distinguished from extra-
cellular matrix (ECM) by the close vicinity of the cell 
membrane. D, A tandem-like FNX (asterisks) at the 
surface of a myofibroblast cultured from tumor-free 
central lung of a smoker. Dense peripheral actin 
belt is seen in the terminus of the cell (arrowhead). 
Another myofibroblast shows plaque-like FNX 
(arrow). E, Adherens-type junction (arrowhead) in 
cells cultured from smokers’ tumor-free central lung. 
F, Plaque-like FNX (asterisk) at the cell surface of a 
cancer-associated myofibroblast. Intracellular dense 
actin belt (arrowhead) and dilated rER (arrow) are 
illustrated. A scale bar is shown. Fn, fibronectin; 
FNX, fibronexus; rER, rough endoplasmic reticulum.
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CAM and particularly those from adenocarcinoma exhibited 
an increased amount of labels for α-SMA when compared with 
myofibroblasts from tumor-free peripheral lung of all patients 
(p = 0.010, Dunnett t test and p = 0.010, independent samples 
t test, respectively, Fig. 4A, C, D, and F) or myofibroblasts 
from tumor-free peripheral lung of nonsmokers (p = 0.035 and 
p = 0.038, t test, respectively). CAM also possessed a trend to 
exhibit more labeling for α-SMA than myofibroblasts from 
tumor-free central lung (p = 0.083, Mann-Whitney U test, 
Fig. 4B–D, Table 3).
When compared systematically, the samples of can-
cer and tumor-free peripheral lung as patient-matched 
pairs CAM expressed more α-SMA labeling than 
tumor-free peripheral (p = 0.007, paired samples t test) 
and central myofibroblasts (p = 0.041, paired samples 
t test). Myofibroblasts from  tumor-free central lung dis-
played slightly increased α-SMA expression when com-
pared with those of peripheral lung (p = 0.053, paired 
samples t test).
CAM and myofibroblasts from nonsmokers and smokers
CAM from smokers showed less labeling for α-SMA 
than those cells from nonsmokers (p = 0.012 Mann-Whitney 
U test, Fig. 4C, D, and G, Table 3).
FIGURE 4.  Visualization and quantification of 
ultrastructural expression of α-smooth muscle 
actin (α-SMA). Immunoelectron micrographs 
reveal the ultrastructural localization of α-SMA 
in  cancer-associated myofibroblasts (CAM). 
Myofibroblasts from tumor-free peripheral (A) and 
central (B) lung with weak α-SMA expression (arrow-
head). C, Intensive labeling for α-SMA (arrowhead) 
in CAM derived from a smoker. D, α-SMA expression 
(arrowheads) in CAM derived from a nonsmoker. E, 
Negative control sample. A scale bar is shown. F and 
G, Quantification of α-SMA expression in CAM and 
myofibroblasts from tumor-free peripheral lung by 
immunoelectron microscopy (IEM; relative number 
of gold particles per μm2). CAM expressed more 
 α-SMA than myofibroblasts from tumor-free periph-
eral lung (p = 0.010, asterisk, F). CAM from smokers 
expressed less α-SMA than those of nonsmokers 
(p = 0.012, asterisk, G). 
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Western Blotting
CAF and fibroblastic cells cultured from  tumor-free  
peripheral and central lung
CAF and especially those from adenocarcinoma 
expressed a higher amount of α-SMA than cell lines composed 
of fibroblasts and myofibroblasts from tumor-free peripheral 
(p = 0.006, t test) and central lung (p = 0.012, Mann-Whitney 
U test, Fig. 5A). CAF expressed more α-SMA than fibroblas-
tic cells from tumor-free peripheral lung (p = 0.003, paired 
samples t test) also when the samples of cancer and tumor-free 
peripheral lung from the same patient were compared.
CAF and fibroblastic cells cultured from  
nonsmokers and smokers.
CAF expressed more α-SMA than fibroblastic cells 
from tumor-free peripheral lung of nonsmokers (p = 0.050, t 
test). Fibroblastic cells from tumor-free central lung of smok-
ers had less α-SMA compared with their counterparts from 
nonsmokers (p = 0.039, Mann-Whitney U test, Fig. 5B).
Collagen Gel Contraction Assay
After incubation for 1 and 2 days, there was no differ-
ence in collagen gel contractions between cells of different 
lung compartments. After the 3-day incubation, collagen gel 
with CAF contracted more than the gel with fibroblastic cells 
from tumor-free peripheral lung (p = 0.022, t test, Fig. 5C). 
When all cell samples were evaluated as a group, the cases 
with myofibroblasts with a moderate or strong amount of 
extracellular component of FNX by TEM demonstrated a 
more contractile phenotype in collagen gel after incubation 
for 1 day (p = 0.008, t test, Fig. 5D).
DISCUSSION
This study describes the ultrastructural features of cul-
tured lung CAM and myofibroblasts from tumor-free periph-
eral and central lung in a relatively large study material that 
was composed of 57 cell lines from 23 patients. As far as we 
are aware, this is the first study conducted on cells cultured 
from lung cancer patients, in which both electron and immu-
noelectron microscopy have been used as the primary evalu-
ation methods. Furthermore, we are not aware of any other 
studies which would have similarly quantified myofibroblas-
tic ultrastructural features in specimens from cancer patients. 
CAM from lung adenocarcinoma and squamous cell carci-
noma expressed more typical myofibroblastic ultrastructural 
features and α-SMA, a marker of myofibroblasts, when com-
pared with the myofibroblasts of tumor-free lung. CAM from 
squamous cell carcinoma exhibited more ECM than those of 
adenocarcinoma. There were no other structural or functional 
differences between CAM or those of cancers. Thus, it can be 
concluded that there were only minor dissimilarities in various 
histological types of lung cancer–associated stromal cells.
FIGURE 5.  Quantification of α-smooth muscle actin (α-SMA) expression by Western blotting and collagen gel contraction 
assay in cancer-associated fibroblasts (CAF) and tumor-free peripheral and central fibroblastic cells. A and B, The expression 
of α-SMA in CAF and tumor-free peripheral and central fibroblastic cells by Western blotting. CAF expressed a higher amount 
of α-SMA than fibroblastic cells from tumor-free peripheral (p = 0.006, asterisks, A) and central lung (p = 0.012, asterisk, A). 
Tumor-free central fibroblastic cells of smokers showed less α-SMA than those of nonsmokers (p = 0.039, asterisk, B). C, The 
contractile capacities of CAF and fibroblastic cells from tumor-free peripheral lung in collagen gel contraction assay. The 
area of collagen gel was measured in different time points (1, 2, and 3 days) and normalized to the original size of gel (%). 
CAF  contracted more in collagen gel than fibroblastic cells from tumor-free peripheral lung (p = 0.022, asterisk, C). D, The 
 association between cell structure and function revealing that the cases consisting of myofibroblasts with more extracellular 
component of fibronexus (FNX) assayed by TEM are more potent to contract in collagen gel (p = 0.008, asterisks).
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More significant differences were seen in association 
with smoking. The cells of smokers displayed less myofi-
broblastic ultrastructural features than those of nonsmokers. 
Moreover, CAF exhibited more contraction in collagen gel 
when compared with the fibroblastic cells of normal periph-
eral lung. Those findings together might point to an associa-
tion between the structural and the functional properties of the 
cells. A positive correlation between the structure and func-
tion was observed also in the expression of extracellular com-
ponent of FNX and contractile capacity in collagen gel. In our 
previous study, a similar phenomenon was observed between 
the level of α-SMA and the invasiveness of cells cultured from 
the patients with idiopathic pulmonary fibrosis (IPF).6
A recent study revealed that invasive lung adenocarci-
nomas expressed more myofibroblasts than pure bronchio-
loalveolar carcinoma, that is, adenocarcinoma in situ (AIS) 
with lepidic growth according to the current international 
multidisciplinary classification,19 and that the number of myo-
fibroblasts associated with lymph node metastasis, high stage, 
high grade, vascular invasion, and shortened survival time.20 
We did not have any AIS in our study material and thus were 
not able to compare the properties of myofibroblasts cultured 
from AIS and invasive adenocarcinomas. CAF from lung 
adenocarcinoma have been shown to express a higher amount 
of α-SMA compared with those normal counterparts,4 a find-
ing which is in line with the present report. In breast cancer, 
CAF have been shown to express more α-SMA than normal 
fibroblasts,21 similarly as found here, and the increase in the 
amount of myofibroblasts was linked to a poor prognosis.22
When CAF and normal lung fibroblasts were studied in 
vitro and in primary tumor stroma in vivo from the patients 
with non–small-cell lung cancer, it was observed that six 
 up-regulated and eight down-regulated genes were associated 
with ECM proteins activation via TGF-β1 pathway, stress 
response, and cell attachment in CAF.23 CAF have been shown 
to participate in the pathogenesis and progression of cancers 
in several ways such as promoting lung cancer metastasis by 
inducing a proinvasive phenotype in the carcinoma cells and 
altering the ECM composition.24 It has been hypothesized 
that interfering with metastasis-promoting pathways and key 
signal molecules in stromal cells could be a way to prevent 
metastasis.25 One potential interaction between CAF and 
carcinoma cells is mediated through the chemokine receptor 
type 4 and its ligand chemokine receptor ligand 12, which are 
related to increased cell migration. Chemokine receptor type 
4–positive cancer cells are able to migrate toward chemokine 
receptor ligand 12–expressing CAF and other stromal cells.25 
Several other factors have been also demonstrated to be asso-
ciated with the regulation of myofibroblasts in cancer, such as 
inhibitors against TGF-β1, epithelial-mesenchymal transition, 
and cell surface integrins αVβ3 and αVβ5, which may have a 
role as anticancer agents.26–28 As suggested by several authors, 
stromal cells including myofibroblasts and fibroblasts might 
be useful target cells for therapeutic interventions in lung can-
cer.1,29 It could be postulated that cultured CAF would be use-
ful not only in research into lung cancer but possibly also in 
searching for the most effective therapeutic treatments for the 
patients. Cell culture of CAF will make it possible to obtain 
cells that could be tested by potential therapeutic agents to 
identify the most suitable therapy for a particular patient. In 
addition, stromal cells in tumors have been shown to possess 
prognostic value,29 and it has been demonstrated that altera-
tions in stromal proteins in lung cancer are associated with 
the prognosis, that is, a high amount of CD99 seems to point 
to better survival of the patients.30 Nonetheless, before one 
can decide whether cultured CAF will be useful in estimating 
prognosis, larger patient material than the present study with 
longer follow-up times would be beneficial.
Fibroblastic cells cultured from peripheral lung of lung 
cancer resection material are often used as controls when 
investigating pulmonary cells from several types of lung 
diseases including lung cancer and IPF. Our results revealed 
that these peripheral fibroblastic cells were a mixture of cells 
with a variety of structures and functions, which depended on 
smoking status. This finding emphasizes the need for an accu-
rate evaluation of the control material and an estimation of 
healthy human lung with normal anatomical and histological 
structures.
Eyden with co-workers31 reported that the in vivo stage 
of myofibroblast differentiation varied in different types of 
tumors from fully matured myofibroblasts to even partial 
smooth muscle cell differentiation, but normal reactive stro-
mal myofibroblasts can be distinguished from tumoral myofi-
broblasts by TEM. As in those previous studies, also this study 
demonstrated that CAM frequently contained cell surface 
bundles of Fn and dilated rER. However, here we observed a 
low accumulation of ECM in contrast to previous results. The 
divergence between the previous and the present findings may 
have resulted from the fact that we used in vitro cell culture, 
whereas previously myofibroblasts have been analyzed in vivo 
in tissues.10,32 It could be speculated that the in vitro cell cul-
ture and the lack of interacting carcinoma cells would affect 
the phenotypes of the myofibroblasts. However, in this present 
and our previous studies, we were able to demonstrate that 
many myofibroblastic ultrastructural features were explicitly 
linked to certain lung diseases in cultured cells, and moreover, 
the phenotype of cultured cells did not reveal changes during 
passages.6 Furthermore, we verified our TEM findings by ana-
lyzing all samples by IEM and the results supported the TEM 
findings, that is, they revealed the distinctive ultrastructural 
labeling of α-SMA in cells cultured from the patients with dif-
ferent kinds of lung diseases and cells cultured from different 
anatomical regions of the lung.
The present and our previous studies are the first dem-
onstrations that have used quantitative methods in IEM and 
systematically analyzed the proteins typically found in myo-
fibroblasts from a relatively large patient material.6 This is 
also the first study to use this IEM method for lung CAM. 
We applied an accurate quantification and observed that 
CAM possessed an increased amount of α-SMA labels when 
compared with myofibroblasts of tumor-free lung. IEM has 
been previously used to evaluate, but not to quantify, the 
localization of α-SMA in subepithelial myofibroblasts in 
the tissues of four patients with ulcerative colitis associated 
with neoplasia.33 Tissue samples from three patients with 
bladder carcinoma were also examined by TEM and IEM, 
673Copyright © 2014 by the International Association for the Study of Lung Cancer
Journal of Thoracic Oncology ®  •  Volume 9, Number 5, May 2014 Myofibroblasts in Lung Cancer
and the carcinoma cells were observed to be surrounded by 
stromal myofibroblasts.34 Labeling for α-SMA and Fn has 
been demonstrated in myofibroblasts derived from rodent 
granulation tissue.14
CAF have been previously studied mainly by Western 
blotting and light microscopy where the general belief is that 
those cells promote neoplastic angiogenesis, invasion, and 
metastasis.4,21,35 In immunohistochemical studies, subepithe-
lial myofibroblasts particularly in pure bronchioloalveolar 
carcinoma were detected as a continuous lining around the 
neoplastic acinar structures, but they were gradually lost and 
replaced by the typical stromal myofibroblasts during cancer 
progression.36 We demonstrated that CAF were more potent 
contractors in the collagen gel than normal lung fibroblastic 
cells, which is in line with the previous study revealing that 
lung CAF achieved an elevated contractile capacity when 
compared with normal fibroblasts.4 In our previous study, 
it was observed that the cells of the IPF patients expressed 
more myofibroblastic ultrastructural features and those cells 
had the highest invasive capacity.6 The invasiveness of those 
cells was associated with the expression of α-SMA. In the 
present study, the frequency of extracellular component of 
FNX in CAM was associated with the increased contraction 
of collagen gel.
Chronic smoking seemed to decrease the amount of 
myofibroblasts. CAM, CAF, and normal lung central fibro-
blastic cells from smokers exhibited fewer myofibroblastic 
features in both the electron microscope and Western blotting. 
Previous cell culture studies have demonstrated that human 
fetal lung fibroblasts37,38 lose their contractile capacities after 
an acute exposure to tobacco smoke and that acute tobacco 
exposure for 2 days increased α-SMA expression in human 
bronchial fibroblasts.39 Those results are partly in line with the 
present findings, indicating that tobacco smoke may interfere 
with myofibroblast structure and transformation. Many previ-
ous studies have experimentally analyzed acute exposures to 
tobacco smoke in vitro, whereas in our study, the long-lasting 
smoking habits of the patients were measured.
We conclude that lung cancer–associated myofibroblasts 
displayed differential ultrastructural and contractile properties 
in collagen gel when compared with the cells of tumor-free 
peripheral and central lungs. In addition, smoking affected the 
structure and function of the cells. The use of cell culture and 
electron microscopy for investigating lung cancer–associated 
myofibroblasts could make it possible to characterize cells for 
prognostic and therapeutic applications. Further studies, how-
ever, are needed to clarify the exact role of ultrastructural and 
functional changes in myofibroblasts during the progression 
of lung diseases.
ACKNOWLEDGMENTS
The authors thank Saara Korpela and Biocenter Oulu 
EM laboratory staff for laboratory and technical skills. A 
part of the study has been published as an abstract. The study 
was supported by the Finnish Anti-Tuberculosis Association 
Foundation, the Väinö and Laina Kivi Foundation, the Jalmari 
and Rauha Ahokas Foundation, a state subsidy of the Oulu 
University Hospital and Kuopio University Hospital, and 
the Health Care Foundation of North Finland. The Swedish 
Heart-Lung Foundation is also acknowledged.
REFERENCES
 1. Otranto M, Sarrazy V, Bonté F, Hinz B, Gabbiani G, Desmoulière A. The 
role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr 
2012;6:203–219.
 2. Archontogeorgis K, Steiropoulos P, Tzouvelekis A, Nena E, Bouros D. 
Lung cancer and interstitial lung diseases: a systematic review. Pulm Med 
2012;2012:315918.
 3. De Wever O, Nguyen QD, Van Hoorde L, et al. Tenascin-C and SF/HGF 
produced by myofibroblasts in vitro provide convergent pro-invasive 
signals to human colon cancer cells through RhoA and Rac. FASEB J 
2004;18:1016–1018.
 4. Horie M, Saito A, Mikami Y, et al. Characterization of human lung 
 cancer-associated fibroblasts in three-dimensional in vitro co-culture 
model. Biochem Biophys Res Commun 2012;423:158–163.
 5. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibro-
blast heterogeneity in the tumor microenvironment. Cancer Biol Ther 
2006;5:1640–1646.
 6. Karvonen HM, Lehtonen ST, Sormunen RT, et al. Myofibroblasts in inter-
stitial lung diseases show diverse electron microscopic and invasive fea-
tures. Lab Invest 2012;92:1270–1284.
 7. Lehtonen S, Karvonen HM, Harju T, et al. Stromal cells can be cul-
tured and characterized from diagnostic bronchoalveolar fluid samples 
obtained from patients with various types of interstitial lung diseases. 
APMIS 2014;4:301–316.
 8. Havenith MG, Dingemans KP, Cleutjens JP, Wagenaar SS, Bosman 
FT. Basement membranes in bronchogenic squamous cell carcinoma: 
an immunohistochemical and ultrastructural study. Ultrastruct Pathol 
1990;14:51–63.
 9. Kaarteenaho R, Sormunen R, Pääkkö P. Variable expression of  tenascin-C, 
osteopontin and fibronectin in inflammatory myofibroblastic tumour of 
the lung. APMIS 2010;118:91–100.
 10. Eyden BP. Brief review of the fibronexus and its significance for myo-
fibroblastic differentiation and tumor diagnosis. Ultrastruct Pathol 
1993;17:611–622.
 11. Eyden B. The myofibroblast: phenotypic characterization as a prerequi-
site to understanding its functions in translational medicine. J Cell Mol 
Med 2008;12:22–37.
 12. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in gran-
ulation tissue and their possible role in wound contraction. Experientia 
1971;27:549–550.
 13. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic 
pulmonary fibrosis. Ultrastructural and immunohistochemical fea-
tures of sites of active extracellular matrix synthesis. Am J Pathol 
1991;138:1257–1265.
 14. Singer II, Kawka DW, Kazazis DM, Clark RA. In vivo co-distribution 
of fibronectin and actin fibers in granulation tissue: immunofluorescence 
and electron microscope studies of the fibronexus at the myofibroblast 
surface. J Cell Biol 1984;98:2091–2106.
 15. Singer II, Kazazis DM, Kawka DW. Localization of the fibronexus at the 
surface of granulation tissue myofibroblasts using double-label immuno-
gold electron microscopy on ultrathin frozen sections. Eur J Cell Biol 
1985;38:94–101.
 16. Silcocks PB. Measuring repeatability and validity of histological diag-
nosis—a brief review with some practical examples. J Clin Pathol 
1983;36:1269–1275.
 17. Karvonen HM, Lehtonen ST, Harju T, et al. Myofibroblast expression 
in airways and alveoli is affected by smoking and COPD. Respir Res 
2013;14:84.
 18. Zagai U, Fredriksson K, Rennard SI, Lundahl J, Sköld CM. Platelets 
stimulate fibroblast-mediated contraction of collagen gels. Respir Res 
2003;4:13.
 19. Travis WD, Brambilla E, Noguchi M, et al. International Association 
for the Study of Lung Cancer/American Thoracic Society/European 
Respiratory Society International Multidisciplinary Classification of lung 
adenocarcinoma. J Thorac Oncol 2011;6:244–285.
 20. Shu H, Li HF. Prognostic effect of stromal myofibroblasts in lung adeno-
carcinoma. Neoplasma 2012;59:658–661.
674 Copyright © 2014 by the International Association for the Study of Lung Cancer
Karvonen et al. Journal of Thoracic Oncology ®  •  Volume 9, Number 5, May 2014
 21. Soon PS, Kim E, Pon CK, et al. Breast cancer-associated fibroblasts 
induce epithelial-to-mesenchymal transition in breast cancer cells. 
Endocr Relat Cancer 2013;20:1–12.
 22. Yamashita M, Ogawa T, Zhang X, et al. Role of stromal myofibroblasts in 
invasive breast cancer: stromal expression of alpha-smooth muscle actin 
correlates with worse clinical outcome. Breast Cancer 2012;19:170–176.
 23. Navab R, Strumpf D, Bandarchi B, et al. Prognostic gene-expression sig-
nature of carcinoma-associated fibroblasts in non-small cell lung cancer. 
Proc Natl Acad Sci U S A 2011;108:7160–7165.
 24. Wood SL, Pernemalm M, Crosbie PA, et al. The role of the 
 tumor-microenvironment in lung cancer-metastasis and its relationship to 
potential therapeutic targets. Cancer Treat Rev 2014;40:558–566.
 25. Saintigny P, Burger JA. Recent advances in non-small cell lung cancer 
biology and clinical management. Discov Med 2012;13:287–297.
 26. Kim J, Hwan Kim S. CK2 inhibitor CX-4945 blocks TGF-β1-induced 
epithelial-to-mesenchymal transition in A549 human lung adenocarci-
noma cells. PLoS One 2013;8:e74342.
 27. Manegold C, Vansteenkiste J, Cardenal F, et al. Randomized phase II 
study of three doses of the integrin inhibitor cilengitide versus docetaxel 
as second-line treatment for patients with advanced non-small-cell lung 
cancer. Invest New Drugs 2013;31:175–182.
 28. Shintani Y, Abulaiti A, Kimura T, et al. Pulmonary fibroblasts induce epi-
thelial mesenchymal transition and some characteristics of stem cells in 
non-small cell lung cancer. Ann Thorac Surg 2013;96:425–433.
 29. Bremnes RM, Dønnem T, Al-Saad S, et al. The role of tumor stroma 
in cancer progression and prognosis: emphasis on carcinoma-asso-
ciated fibroblasts and non-small cell lung cancer. J Thorac Oncol 
2011;6:209–217.
 30. Edlund K, Lindskog C, Saito A, et al. CD99 is a novel prognostic stromal 
marker in non-small cell lung cancer. Int J Cancer 2012;131:2264–2273.
 31. Eyden B, Banerjee SS, Shenjere P, Fisher C. The myofibroblast and its 
tumours. J Clin Pathol 2009;62:236–249.
 32. Eyden B. The fibronexus in reactive and tumoral myofibroblasts: further 
characterisation by electron microscopy. Histol Histopathol 2001;16:57–70.
 33. Okayasu I, Yoshida T, Mikami T, et al. Mucosal remodeling in 
 long-standing ulcerative colitis with colorectal neoplasia: significant 
alterations of NCAM+ or alpha-SMA+ subepithelial myofibroblasts and 
interstitial cells. Pathol Int 2009;59:701–711.
 34. Shimasaki N, Kuroda N, Miyazaki E, et al. The distribution pattern of 
myofibroblasts in the stroma of human bladder carcinoma depends on 
their invasiveness. Histol Histopathol 2006;21:349–353.
 35. De Wever O, Westbroek W, Verloes A, et al. Critical role of N-cadherin 
in myofibroblast invasion and migration in vitro stimulated by 
 colon-cancer-cell-derived TGF-beta or wounding. J Cell Sci 2004;117(Pt 
20):4691–4703.
 36. Matsubara D, Morikawa T, Goto A, Nakajima J, Fukayama M, Niki T. 
Subepithelial myofibroblast in lung adenocarcinoma: a histological indi-
cator of excellent prognosis. Mod Pathol 2009;22:776–785.
 37. Carnevali S, Nakamura Y, Mio T, et al. Cigarette smoke extract inhibits 
fibroblast-mediated collagen gel contraction. Am J Physiol 1998;274(4 Pt 
1):L591–L598.
 38. Wang H, Liu X, Umino T, et al. Effect of cigarette smoke on 
 fibroblast-mediated gel contraction is dependent on cell density. Am J 
Physiol Lung Cell Mol Physiol 2003;284:L205–L213.
 39. Milara J, Serrano A, Peiró T, et al. Aclidinium inhibits human lung fibro-
blast to myofibroblast transition. Thorax 2012;67:229–237.
